SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Strategies & Market Trends : YEEHAW CANDIDATES -- Ignore unavailable to you. Want to Upgrade?


To: Galirayo who wrote (10953)8/26/2005 8:50:55 AM
From: Galirayo  Read Replies (1) | Respond to of 23958
 
[DFIB] 8to10NPL Update. And News.

stockcharts.com[w,a]dacayiay[dc][pb50!c20!f][vc60][iut!Ua12,26,9!Uv25]&pref=G

AP
Japan OKs Cardiac Science Defibrillator
Thursday August 25, 6:47 pm ET
Japanese Regulators Approve More Advanced Version of Cardiac Science Defibrillator

IRVINE, Calif. (AP) -- Cardiac Science Inc. said Thursday that the Japanese government approved its updated automatic public-access defibrillator, or AED, ending a review process that stretched out over two years.
ADVERTISEMENT


Shares of the maker of emergency defibrillators and related medical devices jumped 9.7 percent to $1.13 in after-hours trading. Its stock closed up 1 cent at $1.03 in regular session on the Nasdaq.

Cardiac Science has sold an earlier version of the defibrillator through Nihon Kohden Corp. since 2002, but the lengthy review of the more advanced product allowed a competitor with an approved product to capture some of its market share, the company said.

The firm's 2005 shipments to Japan were sharply lower than 2004 shipments as a result.

The "biphasic" product -- which uses a more sophisticated current flow -- will be sold under the CardioLife brand by Japan's largest medical device maker, Nihon Kohden.

"The product is now ready for shipment and we are confident that with our biphasic version AED will allow us to regain our previous momentum," said Chairman and Chief Executive Raymond W. Cohen, in a statement.